erythrosine has been researched along with Retinopathy of Prematurity in 22 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Retinopathy of Prematurity: A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thalidomide is a well-known anti-angiogenic drug." | 5.35 | The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity. ( Katz, G; Pri-Chen, S; Rabinowitz, R; Rosner, M; Spierer, A, 2008) |
| "Animals that received ibuprofen during hyperoxia exposure had a significantly lower median (25th, 75th quartile) retinopathy score of 6 (5, 7." | 3.72 | Ibuprofen improves oxygen-induced retinopathy in a mouse model. ( Barr, SM; Geng, Y; Higgins, RD; Sharma, J; Yun, Y, 2003) |
| "Retinal neovascularization was observed by fluorescence angiography and was quantified by counting the endothelial nuclei protruding into the vitreous cavity after hematoxylin-eosin staining." | 1.37 | Netrin-1 overexpression in oxygen-induced retinopathy correlates with breakdown of the blood-retina barrier and retinal neovascularization. ( Jiang, J; Liu, D; Liu, JL; Tian, XF; Xia, XB; Xiong, SQ, 2011) |
| "Retinal neovascularization was evaluated by angiography with injection of fluorescein-dextran and quantification of neovascular proliferative retinopathy after 5 days in room air." | 1.35 | Suppression of retinal neovascularization by small-interference RNA targeting erythropoietin. ( Jiang, J; Xia, XB; Xiong, SQ; Xu, HZ, 2009) |
| "Thalidomide is a well-known anti-angiogenic drug." | 1.35 | The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity. ( Katz, G; Pri-Chen, S; Rabinowitz, R; Rosner, M; Spierer, A, 2008) |
| "Riluzole is a Food and Drug Administration-approved anti-ALS drug with a favorable adverse effect profile." | 1.34 | Insulin increases retinal hemorrhage in mild oxygen-induced retinopathy in the rat: inhibition by riluzole. ( Cho, KS; Chung, H; Koh, JY; Yoo, MH; Yoon, YH, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.09) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 8 (36.36) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Gonzalez, A | 1 |
| Agarwal-Sinha, S | 1 |
| Chen, X | 1 |
| Mangalesh, S | 1 |
| Tran-Viet, D | 1 |
| Freedman, SF | 1 |
| Vajzovic, L | 1 |
| Toth, CA | 1 |
| Blair, MP | 1 |
| Hilkert Rodriguez, S | 1 |
| Chan, RVP | 1 |
| Shapiro, MJ | 1 |
| Lepore, D | 1 |
| Ji, MH | 1 |
| Quinn, G | 1 |
| Bai, YJ | 1 |
| Huang, LZ | 1 |
| Zhou, AY | 1 |
| Zhao, M | 1 |
| Yu, WZ | 1 |
| Li, XX | 1 |
| Dal Monte, M | 1 |
| Ristori, C | 1 |
| Cammalleri, M | 1 |
| Bagnoli, P | 1 |
| Xiong, SQ | 2 |
| Xia, XB | 2 |
| Xu, HZ | 1 |
| Jiang, J | 2 |
| Tian, XF | 1 |
| Liu, D | 1 |
| Liu, JL | 1 |
| Newman, H | 1 |
| Shapira, S | 1 |
| Spierer, O | 1 |
| Kraus, S | 1 |
| Rosner, M | 3 |
| Pri-Chen, S | 3 |
| Loewenstein, A | 1 |
| Arber, N | 1 |
| Barak, A | 1 |
| Rabinowitz, R | 2 |
| Priel, A | 1 |
| Spierer, A | 2 |
| Zhang, HB | 1 |
| Sun, NX | 1 |
| Liang, HC | 1 |
| Xiao, XH | 1 |
| Liu, XN | 1 |
| Wang, YN | 1 |
| Sharma, J | 1 |
| Barr, SM | 1 |
| Geng, Y | 1 |
| Yun, Y | 1 |
| Higgins, RD | 3 |
| Yoo, MH | 1 |
| Yoon, YH | 1 |
| Chung, H | 1 |
| Cho, KS | 1 |
| Koh, JY | 1 |
| Katz, G | 1 |
| Smith, LE | 2 |
| Wesolowski, E | 2 |
| McLellan, A | 1 |
| Kostyk, SK | 1 |
| D'Amato, R | 1 |
| Sullivan, R | 1 |
| D'Amore, PA | 1 |
| Penn, JS | 1 |
| Tolman, BL | 1 |
| Bullard, LE | 1 |
| Yossuck, P | 2 |
| Yan, Y | 2 |
| Tadesse, M | 2 |
| Lonchampt, M | 1 |
| Pennel, L | 1 |
| Duhault, J | 1 |
| O'Grady, GE | 2 |
| Flynn, JT | 2 |
| Herrera, JA | 2 |
| Cantolino, SJ | 1 |
| Israel, C | 1 |
| Justice, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care (BabySTEPS)[NCT02887157] | 191 participants (Actual) | Observational | 2016-07-22 | Completed | |||
| Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care 2 and School Age Follow on Study (BabySTEPS2)[NCT04995341] | 236 participants (Anticipated) | Interventional | 2021-08-16 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
22 other studies available for erythrosine and Retinopathy of Prematurity
| Article | Year |
|---|---|
Fluorescein angiographic features post-intravitreal bevacizumab for retinopathy of prematurity: can they support rescue laser photocoagulation to the avascular retina.
Topics: Angiogenesis Inhibitors; Bevacizumab; Child, Preschool; Fluorescein Angiography; Fluoresceins; Gesta | 2020 |
Fluorescein Angiographic Characteristics of Macular Edema During Infancy.
Topics: Birth Weight; Blood-Retinal Barrier; Capillary Permeability; Child, Preschool; Cross-Sectional Studi | 2018 |
Fluorescein Angiographic Characteristics of Macular Edema During Infancy.
Topics: Birth Weight; Blood-Retinal Barrier; Capillary Permeability; Child, Preschool; Cross-Sectional Studi | 2018 |
Fluorescein Angiographic Characteristics of Macular Edema During Infancy.
Topics: Birth Weight; Blood-Retinal Barrier; Capillary Permeability; Child, Preschool; Cross-Sectional Studi | 2018 |
Fluorescein Angiographic Characteristics of Macular Edema During Infancy.
Topics: Birth Weight; Blood-Retinal Barrier; Capillary Permeability; Child, Preschool; Cross-Sectional Studi | 2018 |
Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226).
Topics: Bevacizumab; Fluoresceins; Follow-Up Studies; Humans; Infant, Newborn; Intravitreal Injections; Reti | 2018 |
Reply.
Topics: Bevacizumab; Fluoresceins; Follow-Up Studies; Humans; Infant, Newborn; Intravitreal Injections; Reti | 2018 |
Antiangiogenesis effects of endostatin in retinal neovascularization.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Apoptosis; Blotting, Western; Cell Movement; Cel | 2013 |
Effects of somatostatin analogues on retinal angiogenesis in a mouse model of oxygen-induced retinopathy: involvement of the somatostatin receptor subtype 2.
Topics: Animals; Animals, Newborn; Blotting, Western; Dextrans; Enzyme-Linked Immunosorbent Assay; Female; F | 2009 |
Suppression of retinal neovascularization by small-interference RNA targeting erythropoietin.
Topics: Animals; Animals, Newborn; Base Sequence; Blotting, Western; Cell Culture Techniques; Dextrans; Dise | 2009 |
Netrin-1 overexpression in oxygen-induced retinopathy correlates with breakdown of the blood-retina barrier and retinal neovascularization.
Topics: Animals; Blood-Retinal Barrier; Blotting, Western; Capillary Permeability; Dextrans; Disease Models, | 2011 |
Involvement of CD24 in angiogenesis in a mouse model of oxygen-induced retinopathy.
Topics: Animals; Animals, Newborn; CD24 Antigen; Dextrans; Disease Models, Animal; Fluoresceins; Humans; Hyp | 2012 |
Avastin treatment reduces retinal neovascularization in a mouse model of retinopathy of prematurity.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Antibodies, Monoclonal, Humanized; Bevacizumab; | 2012 |
17-Alpha-estradiol ameliorating oxygen-induced retinopathy in a murine model.
Topics: Animals; Animals, Newborn; Capillary Permeability; Dextrans; Disease Models, Animal; Dose-Response R | 2012 |
Ibuprofen improves oxygen-induced retinopathy in a mouse model.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Dextrans; Disease Models, Animal | 2003 |
Insulin increases retinal hemorrhage in mild oxygen-induced retinopathy in the rat: inhibition by riluzole.
Topics: Animals; Animals, Newborn; Blotting, Western; Dextrans; Disease Models, Animal; Enzyme-Linked Immuno | 2007 |
The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Dextrans; Disease Models, Animal; Fluoresceins; | 2008 |
Oxygen-induced retinopathy in the mouse.
Topics: Animals; Dextrans; Disease Models, Animal; Fluorescein Angiography; Fluoresceins; Fundus Oculi; Glia | 1994 |
Effect of light on oxygen-induced retinopathy in the mouse.
Topics: Animals; Dark Adaptation; Dextrans; Disease Models, Animal; Fluorescein Angiography; Fluoresceins; F | 1994 |
Effect of a water-soluble vitamin E analog, trolox C, on retinal vascular development in an animal model of retinopathy of prematurity.
Topics: Animals; Animals, Newborn; Antioxidants; Capillaries; Chromans; Dextrans; Disease Models, Animal; Fl | 1997 |
Dexamethasone and critical effect of timing on retinopathy.
Topics: Animals; Animals, Newborn; Dexamethasone; Dextrans; Disease Models, Animal; Fluoresceins; Glucocorti | 2000 |
Hyperoxia/normoxia-driven retinal angiogenesis in mice: a role for angiotensin II.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; | 2001 |
Lack of effect of gender on retinopathy in the mouse.
Topics: Animals; Animals, Newborn; Dextrans; Disease Models, Animal; Female; Fluoresceins; Humans; Hyperoxia | 2001 |
The clinical course of retrolental fibroplasia in premature infants.
Topics: Cryosurgery; Fluoresceins; Fundus Oculi; Humans; Infant, Newborn; Oxygen Inhalation Therapy; Photogr | 1972 |
Ophthalmoscopic monitoring of oxygen therapy in premature infants. Fluorescein angiography in acute retrolental fibroplasia.
Topics: Acute Disease; Female; Fluoresceins; Fundus Oculi; Humans; Infant; Infant, Newborn; Male; Ophthalmos | 1971 |